Flot.bio x Philip Hemme artwork

Life Sciences · Flot.bio

Flot.bio x Philip Hemme

by Flot.bio

Watch the #1 Biotech Podcast in Europe to grow. Hosted by Philip Hemme. 25k monthly views. Free. Guests include Antoine Papiernik @Sofinnova, Werner Lanthaler @Evotec, Ingmar Hoerr @CureVac, Bernat Olle @Vedanta, Johannes Fruehauf @BioLabs, Rodger Novak @CRISPR Tx, Agnete Fredriksen @Nykode, Mike Ward, Thomas Clozel @Owkin, Marc de Garidel @Abivax, Sander van Deventer @VectorY & Forbion, Jens Nielsen @BII, Edwin Moses, Bahija Jallal @Immunocore, and more. Your host Philip animates the conversation to dig out exciting, and sometimes contrarian, ideas.

Latest episodes

Showing 20 · updated from the feed

Building a Liposome Biotech without VCs | Stefan Halbherr, InnoMedica | E64 [Sponsored]

Nanomedicines specialist InnoMedica began in the cellar of an office building for two years before building its own nanofactory near Fribourg.Stefan and I talked about ho

Nov 12
1 h 11 min

Red Hot Rare Diseases and Europe’s record funding with Regina Hodits, Angelini Ventures | E63

Regina Hodits, who I have known for many years, spent 15 years at Wellington Partners before joining Angelini Ventures in 2025. The corporate venture fund now manages clo

Oct 13
31 min

MedinCell CEO on Long-Acting Drugs & France’s $1B Biotech Club | Christophe Douat | E62

Christophe has run MedinCell since 2009, when it was eight people in a converted garage. Today it's one of only three French biotechs to ever cross $1B on Euronext.With o

Sep 28
57 min

Billionaire wild bets on Consumer Biotech, GLP-1s, and psychedelics | Christian Angermayer | E61

Christian Angermayer became a multimillionaire before turning 25 thanks to the merger of Alnylam with Ribopharma. We talk about his diverse investment appetite and the ri

Jul 6
1 h 14 min

ImCheck ex-CEO on ASCO Oncology Trends, $1.2B Exit and French Biotech | Pierre d’Epenoux | E60

After ImCheck’s inception in 2015, Pierre took the helm through clinical development and guided the startup to a $1.2B buyout by Ipsen in 2025. In a session at the Kadan

Jun 8
47 min

CEO Jean-François Brepson on Scaling a CRO, and Selling to Charles River | E59 [Sponsored]

Founded in 2010, the Institut Pasteur spinout PathoQuest sold to top CRO Charles River for $70M this year, a product of years of collaboration and stepwise investments.Je

Jun 1
1 h 01 min

Ex-CEO of Incyte Hervé Hoppenot on 10x Growth, Biotech Cycles, and Breaking Bureaucracy | E58

When Hervé joined Incyte in 2014, the launch of lead product Jakafi in the US was choppy. By the time he left in 2025, he had grown their revenue from $300 million to a w

May 25
58 min

Christoph Lengauer, Curie.Bio | Biotech Founders, Venture Capital | E57

We admire the mountains of Austria with the co-founder of Curie.Bio, a founder-friendly fund that now manages $1.25B and backs 38 portfolio companies.We discuss Curie.Bio

May 11
1 h 19 min

Sander Slootweg, Forbion 🇳🇱 | European Biotech Investment, Venture Capital | E56

Forbion celebrates its 20th anniversary this year, with a whopping €5 billion raised so far. Sander marks the occasion by discussing how Forbion plans to promote life sci

Apr 13
1 h 06 min

Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]

Antibiotic-resistant superbugs could become a greater threat than cancer. Bruno and Pedro at the startup Immunethep explain how they’re tackling the crisis with vaccines.

Apr 8
1 h 02 min

António Portela, Bial 🇵🇹 | Parkinson’s, Family-Owned Biotech | E54

We dive into Bial’s meteoric journey from a small pharmacy in Porto to Portugal’s biggest biopharma company, all while still being 100% family owned. We cover Bial’s pi

Mar 30
31 min

Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53

Novonesis arose from a 2023 merger of Novozymes and Chr Hansen, and is a highly profitable powerhouse. CSO Claus talks about the applications of Novonesis’ technology, it

Feb 17
1 h 10 min

Sten R. Sörensen, Cereno Scientific 🇸🇪 | Drug Repurposing, Retail Investors | E52 [Sponsored]

At the beginning of 2025, Sten R. Sörensen announced Cereno Scientific’s positive Phase 2a results in PAH for lead asset CS1. He’s now moving forward with a global Phase

Feb 9
1 h 24 min

Fredrik Tiberg, Camurus 🇸🇪 | Opioid Crisis, Long-Acting Injections | E51

Founded in 1991, Camurus has grown into a $4B biotech with two products in the market, a rich pipeline, and 290 employees.Fredrik explains how Camurus’ long-acting inject

Feb 2
1 h 00 min

Alessandro Riva, Transgene | Cancer Vaccines, Oncolytic Viruses | E50

Founded in 1979, Transgene has transformed itself into a leading personalized cancer vaccine player. Alessandro talks about the transformation, his history in cell therap

Jan 12
1 h 05 min

Pascal Touchon 🇫🇷 | Cell Therapy, Jeito, Kymriah | E49

Pascal Touchon unpacks why the next CAR-T innovations, including allogeneic and in vivo therapies, are going to be so exciting. The cell therapy master outlines his cent

Jan 6
1 h 14 min

Werner Lanthaler 🇦🇹 | Biopharma AI, CDMO, Antibody Optimization | E48

Why have early AI drug-discovery companies often overpromised but underdelivered? Biology is still complex and hard to solve, Werner told Philip in Vienna.We revisit Wern

Dec 1 2025
59 min

Thomas Lingelbach, Valneva | Vaccines, Lyme Disease | E47

Valneva now has three commercialized vaccines, and a Lyme disease candidate in Phase 3. Philip quizzes CEO Thomas Lingelbach about everything. They also discuss the curre

Nov 24 2025
44 min

Marc de Garidel, Abivax 🇫🇷 | Ulcerative Colitis, Inflammation | E46

When Abivax released stunning phase 3 results for ulcerative colitis, its 600% stock price surge froze Euronext for 45 minutes. Philip meets Abivax CEO Marc de Garidel i

Nov 17 2025
53 min

Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45

As Philip travels to France, Nanobiotix CEO Laurent Lévy discusses how the company broke into Europe’s exclusive $1 billion biotech club, alongside the likes of Abivax an

Nov 10 2025
50 min

More podcasts like Flot.bio x Philip Hemme

Popular shows in Life Sciences, for your next listen.

Browse charts by category

Daily updated Apple Podcasts rankings for the United States.

About Flot.bio x Philip Hemme on Reason.fm

Here you find the Apple Podcasts chart positions of Flot.bio x Philip Hemme, its latest episodes to listen to directly, and reviews from listeners. Rankings are updated daily for the United States.

Contact

Questions or issues? Reach us at hello@reason.fm

0:000:00